JP Morgan Chase
MGRM

JP Morgan Chase’s Monogram Orthopaedics MGRM Stock Holding History

JP Morgan Chase’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48
Closed -$114 – 7580
2024
Q4 		$114 Sell
48
-2
-4% -$5 ﹤0.01% 6991
2024
Q3 		$133 Hold
50
– – ﹤0.01% 6961
2024
Q2 		$108 Sell
50
-7,498
-99% -$16.4K ﹤0.01% 6876
2024
Q1 		$18.4K Buy
7,548
+7,262
+2,539% +$21.4K ﹤0.01% 6249
2023
Q4 		$984 Buy
+286
New +$862 ﹤0.01% 6834

Other funds holding MGRM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $11.8B AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase's MGRM Position: Q1 2025 in Review

JP Morgan Chase sold out of Monogram Orthopaedics (MGRM) in Q1 2025, closing a stake of 48 shares — an estimated $114 sold.

JP Morgan Chase first reported a position in MGRM in Q4 2023 and held it in 5 quarters. The position peaked at $18.4K in Q1 2024. 42 funds tracked by Wall St. Rank hold MGRM as of Q1 2025.

  • JP Morgan Chase reported no remaining Monogram Orthopaedics position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 48 Monogram Orthopaedics shares in Q1 2025, an estimated $114.
  • JP Morgan Chase first reported a position in Monogram Orthopaedics in Q4 2023 and held it in 5 quarters.
  • JP Morgan Chase's Monogram Orthopaedics position peaked at $18.4K in Q1 2024.
  • 42 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.